Humana Inc. $HUM Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lessened its stake in shares of Humana Inc. (NYSE:HUM) by 1.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 295,225 shares of the insurance provider’s stock after selling 3,582 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Humana were worth $76,809,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Elevation Point Wealth Partners LLC purchased a new stake in shares of Humana during the second quarter valued at $32,000. Mather Group LLC. purchased a new stake in Humana during the 3rd quarter valued at about $34,000. AlphaCore Capital LLC acquired a new position in shares of Humana in the second quarter valued at about $39,000. Private Wealth Management Group LLC lifted its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. boosted its position in Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after buying an additional 193 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a report on Thursday, December 18th. Jefferies Financial Group upgraded Humana from a “hold” rating to a “buy” rating and lifted their price objective for the company from $253.00 to $313.00 in a research note on Friday, December 5th. Guggenheim restated a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Finally, The Goldman Sachs Group reduced their price target on Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research report on Monday, November 24th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $292.05.

Humana Price Performance

NYSE:HUM opened at $274.17 on Thursday. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock’s 50-day moving average price is $254.24 and its 200-day moving average price is $263.20. The stock has a market capitalization of $32.98 billion, a PE ratio of 25.70, a price-to-earnings-growth ratio of 2.26 and a beta of 0.45.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.16 earnings per share. As a group, equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana’s dividend payout ratio is currently 33.18%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.